期刊文献+

软组织肿瘤靶向治疗进展 被引量:1

软组织肿瘤靶向治疗进展
原文传递
导出
摘要 软组织肿瘤(soft tissue tumor)是不同组织成分形成的间叶源性肿瘤,占所有恶性肿瘤的1%左右。目前,有超过50种以上的组织亚型,但最常见的为恶性纤维组织细胞瘤(28%),平滑肌肉瘤(12%),脂肪肉瘤(15%),滑膜肉瘤(10%)和恶性周围神经鞘瘤(6%)。尽管具有不同的组织亚型,但其表现有一些共同的特征,如大部分肿瘤的临床习性同部位、组织学分级和肿瘤大小有关。
出处 《中国实用外科杂志》 CSCD 北大核心 2013年第2期159-161,166,共4页 Chinese Journal of Practical Surgery
关键词 软组织肿瘤 靶向治疗 soft tissue tumor targeted therapy
  • 相关文献

参考文献4

二级参考文献50

  • 1I-ShyanSheen,Kuo-ShyangJeng,Shou-ChuanShih,Chih-RoaKao,Wen-HsingChang,Horng-YuanWang,Po-ChuanWang,Tsang-EnWang,Li-RungShyung,Chih-ZenChen.Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(2):187-192. 被引量:41
  • 2VERWEIJ J, CASALI PG, ZALCBERG J, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomized trial [ J ]. Lancet, 2004, 364 ( 9440 ) : 1127- 1134.
  • 3VAN GLABBEKE M, VERWEU J, CASALI PG, et aL Initial and late resistance to imatinib in advanced gastro-intestinal stromal tumors are predicted by different prognostic factors: a European Organization for Research and Treatment of Cancer-ltalian Sarcoma Group-Australasian Gastrointestinal Trials Group Study[ J]. J Clin Oncol, 2005 23(24) :5795-804.
  • 4FLETCHER J A, CORLESS C L, DIMITRIJEVIC S, et al. Mechanisms of resistance to imatinib mesylate in advanced gastrointestinal stromal[C]. Proc Am Soc Clin Oncol, 2003, 22: 815.
  • 5THERASSE P, ARBUCK S G, EISENHAUER E A, et al. New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada[J]. J Natl Cancer lnst, 2000, 92(3) :205-216.
  • 6PAULS K, MERKELBACH-BRUSE S, THAL D, et al. PDGFR-α and c-kit mutated gastrointestinal stromal tumors (GISTs) are characterized by distinctive histological and immunohistochemical features[ J]. Histopathology, 2005, 46 (2) : 166-175.
  • 7WARDELMANN E, LOSEN I, HANS V, et al. Deletion of Trp- 557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors [ J ]. lnt J Cancer, 2003, 106 (6) :887-895.
  • 8WARDELMANN E, HRYCHYK A, MERKELBACH-BRUSE S, o et al. Association of platelet-derived growth factor receptor a mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors [ J ]. J Mol Diagn, 2004, 6(3) :197-204.
  • 9KIKUCHI H, YAMASHITA K, KAWABATA T, et al. Immunohistochemical and genetic features of gastric and metastatic liver gastrointestinal stromal tumors : Sequential analyses [ J ]. Cancer Sci, 2006, 97(2) :127-132.
  • 10WARDELMANN E,MERKELBACH-BRUSE S,PAULS K,et al. Polyclonal evolution of multiple secondary K/T mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate [J]. Clin Cancer Res, 2006, 12(6) :1743-1749.

共引文献47

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部